Comparison between Vivimed Labs IPO and Yash Papers FPO.
Vivimed Labs IPO is a Mainboard Fixed Price IPO proposed to list at BSE, NSE while Yash Papers FPO is a Mainboard Fixed Price proposed to list at BSE.
The total issue size of Vivimed Labs IPO is up to ₹17.51 Cr whereas the issue size of the Yash Papers FPO is up to ₹18.82 Cr. The final issue price of Vivimed Labs IPO is ₹70.00 per share and of Yash Papers FPO is ₹14.00 per share.
| Vivimed Labs IPO | Yash Papers FPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹70.00 per share | ₹14.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 25,01,429 shares | 1,34,40,000 shares |
| Fresh Issue Size (Amount) | up to ₹17.51 Cr | up to ₹18.82 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 25,01,429 shares | 1,34,40,000 shares |
| Issue Size Total (Amount) | up to ₹17.51 Cr | up to ₹18.82 Cr |
Vivimed Labs IPO opens on Jul 09, 2005, while Yash Papers FPO opens on Jun 30, 2005. The closing date of Vivimed Labs IPO and Yash Papers FPO is Jul 13, 2005, and Jul 08, 2005, respectively.
Vivimed Labs IPO P/E ratio is , as compared to Yash Papers FPO P/E ratio of .
| Vivimed Labs IPO | Yash Papers FPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 55.13 | 40.451 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 36.14 | 23.83 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 23.14 | 18.80 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Vivimed Labs IPO Retail Individual Investors (RII) are offered 9,25,000 shares while in Yash Papers FPO retail investors are offered 9,25,000 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Vivimed Labs IPO and 0 shares in Yash Papers FPO.
| Vivimed Labs IPO | Yash Papers FPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 0 shares | 0 shares |
| NII | 9,25,000 shares | 67,20,000 shares |
| RII | 9,25,000 shares | 67,20,000 shares |
| Employee | 50,000 shares | 0 shares |
| Others | ||
| Total | 25,00,000 shares | 1,34,40,000 shares |
Vivimed Labs IPO subscribed in total, whereas Yash Papers FPO subscribed .
